Everads to Present Trial Results at ASRS 2025 with New Injector
30 Jul 2025 //
PR NEWSWIRE
Everads to Present Five Abstracts at ARVO 2025
01 May 2025 //
PR NEWSWIRE
Everads Enters Agreement with Kriya for Development of Ocular Gene Therapy
27 Sep 2023 //
PR NEWSWIRE
VivaVision and Everads Collaborate to Develop Durable and Effective Therapies
06 Jan 2023 //
PR NEWSWIRE
Everads Ink Collaboration to Evaluate its Suprachoroidal Delivery Technology
30 Jun 2021 //
PR NEWSWIRE

Market Place
Sourcing Support